About the Authors
- Virginie Dutoit-Lefèvre
-
Contributed equally to this work with: Virginie Dutoit-Lefèvre, Sylvain Dubucquoi
* E-mail: virginiedutoitlefevre@gmail.com
Affiliations Institut d’Immunologie, Centre de Biologie Pathologie et Génétique, Centre Hospitalier Régional Universitaire, Lille, France, UMR 995, LIRIC, INSERM, Lille, France, EA 2686, Univ Lille Nord de France, Lille, France
- Sylvain Dubucquoi
-
Contributed equally to this work with: Virginie Dutoit-Lefèvre, Sylvain Dubucquoi
Affiliations Institut d’Immunologie, Centre de Biologie Pathologie et Génétique, Centre Hospitalier Régional Universitaire, Lille, France, UMR 995, LIRIC, INSERM, Lille, France, EA 2686, Univ Lille Nord de France, Lille, France
- David Launay
-
Affiliations UMR 995, LIRIC, INSERM, Lille, France, EA 2686, Univ Lille Nord de France, Lille, France, Service de Médecine Interne et d’Immunologie clinique, Centre National de Référence Maladies rares, Centre Hospitalier Régional Universitaire, Lille, France
- Vincent Sobanski
-
Affiliations UMR 995, LIRIC, INSERM, Lille, France, EA 2686, Univ Lille Nord de France, Lille, France, Service de Médecine Interne et d’Immunologie clinique, Centre National de Référence Maladies rares, Centre Hospitalier Régional Universitaire, Lille, France
- Patricia Dussart
-
Affiliations Institut d’Immunologie, Centre de Biologie Pathologie et Génétique, Centre Hospitalier Régional Universitaire, Lille, France, UMR 995, LIRIC, INSERM, Lille, France, EA 2686, Univ Lille Nord de France, Lille, France
- Philippe Chafey
-
Affiliations INSERM U1016, Institut Cochin, Paris, France, UMR 8104, CNRS Paris, France, Plate-forme Protéomique 3P5, Univ Paris Descartes, Sorbonne Paris Cité, Paris, France
- Cédric Broussard
-
Affiliations INSERM U1016, Institut Cochin, Paris, France, UMR 8104, CNRS Paris, France, Plate-forme Protéomique 3P5, Univ Paris Descartes, Sorbonne Paris Cité, Paris, France
- Sophie Duban-Deweer
-
Affiliations EA 2686, Univ Lille Nord de France, Lille, France, LBHE, EA 2465, UArtois, Lens, France
- Patrick Vermersch
-
Affiliations UMR 995, LIRIC, INSERM, Lille, France, EA 2686, Univ Lille Nord de France, Lille, France, Service de Neurologie D, Centre Hospitalier Régional Universitaire, Lille, France
- Lionel Prin
-
Affiliations Institut d’Immunologie, Centre de Biologie Pathologie et Génétique, Centre Hospitalier Régional Universitaire, Lille, France, UMR 995, LIRIC, INSERM, Lille, France, EA 2686, Univ Lille Nord de France, Lille, France
- Didier Lefranc
-
Affiliations UMR 995, LIRIC, INSERM, Lille, France, EA 2686, Univ Lille Nord de France, Lille, France
Competing Interests
Pfizer and Merck Serono provided funding towards this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: VDL SD DLa DLe. Performed the experiments: VDL VS PD CB SDD DLe. Analyzed the data: VDL VS SD DLa CB DLe. Contributed reagents/materials/analysis tools: VDL PD PC CB SDD DLe. Wrote the paper: VDL SD DLa PD PC CB SDD PV LP DLe.